Mitochondrial Replacement Techniques : Examining Collective Representation in Emerging Technologies Governance.

Area of Science:

• Bioethics
• Health Governance
• Patient Advocacy

Background:

• Mitochondrial replacement techniques (MRTs) represent emerging biotechnologies with significant ethical and social implications.
• Patient perspectives are crucial in navigating the translation of novel health technologies into clinical practice.
• Understanding collective representation in health governance is key to integrating patient voices in policy-making.

Purpose of the Study:

• To explore patient and scientist perspectives on mitochondrial replacement techniques (MRTs) in Europe, focusing on Germany.
• To analyze the complexities of collective representation and patient participation in health governance concerning emerging technologies.
• To examine how patient solidarity and community identity shape support for legalizing MRTs.

Main Methods:

• Qualitative research approach utilizing observations and document analyses.
• In-depth interviews with eight leaders of mitochondrial disease patient organizations.
• Analysis of patient and scientist viewpoints on MRTs and their clinical translation.

Main Results:

• A strong sense of global community and solidarity among mitochondrial disease patients influences support for legalizing MRTs.
• Normative expectations of participatory governance may restrict deeper patient engagement with the multifaceted ethical, social, and political aspects of MRTs.
• Potential for silencing diverse or dissenting patient experiences regarding technological advancements.

Conclusions:

• Collective representation, driven by patient solidarity, plays a significant role in the discourse surrounding mitochondrial replacement techniques.
• Current participatory governance models may inadvertently limit comprehensive patient involvement in complex bioethical debates.
• Further research is needed to ensure inclusive and diverse patient voices are heard in the development and implementation of emerging health technologies.